Decrease of serum malondialdehyde in patients treated with chlorpromazine

Clin Chim Acta. 1987 Nov 16;169(2-3):329-32. doi: 10.1016/0009-8981(87)90334-2.

Abstract

Malondialdehyde determination in serum from schizophrenic patients before and after treatment with chlorpromazine showed that, after treatment, patients had significantly lower values than before. The antioxidant properties of chlorpromazine can be related to its effect on the level of serum lipid peroxides and possibly to its neuroleptic action.

MeSH terms

  • Adult
  • Aged
  • Chlorpromazine / adverse effects*
  • Chlorpromazine / therapeutic use
  • Depression, Chemical
  • Humans
  • Male
  • Malonates / blood*
  • Malondialdehyde / blood*
  • Middle Aged
  • Schizophrenia / blood
  • Schizophrenia / drug therapy
  • Spectrophotometry, Infrared

Substances

  • Malonates
  • Malondialdehyde
  • Chlorpromazine